A. M. Achim, M. Maziade, and É. Raymond, How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association, Schizophr Bull, vol.37, pp.811-821, 2011.

D. Bailly, M. Viellard, and H. Duverger, Un diagnostic méconnu: la schizophrénie chez l'enfant, Ann Méd Psychol, vol.161, pp.652-659, 2003.

F. J. Baylé, P. M. Llorca, and J. P. Olié, Anxiété et schizophrénie : situation actuelle, Ann Méd Psychol, vol.158, pp.741-749, 2000.

P. M. Llorca, La schizophrénie, Encyclopédie orphanet. Inserm, 2004.

M. Bogren, C. Mattisson, and K. Tambs, Predictors of psychosis: a 50-year follow-up of the Lundby population, Eur Arch Psychiatry Clin Neurosci, vol.260, pp.113-125, 2010.

N. Muller, Mechanisms of relapse prevention in schizophrenia, Pharmacopsychiatry, vol.37, pp.141-147, 2004.

K. H. Nuechterlein, D. J. Miklowitz, and J. Ventura, Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples, Psychiatry Res, vol.144, pp.153-166, 2006.

S. Pallanti, L. Quercioli, and E. Hollander, Social anxiety in outpatients with schizophrenia: a relevant cause of disability, Am J Psychiatry, vol.161, pp.53-58, 2004.

A. Picardi, P. Rucci, and G. Girolamo, The quality of life of the mentally ill living in residential facilities, Eur Arch Psychiatry Clin Neurosci, vol.256, pp.372-381, 2006.

L. Lecardeur, E. Stip, and M. Giguere, Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized study, Schizophr Res, vol.111, pp.153-158, 2009.

C. Steel, T. Wykes, and A. Ruddle, Can we harness computerised cognitive bias modification to treat anxiety in schizophrenia? A first step highlighting the role of mental imagery, Psychiatry Res, vol.178, pp.451-455, 2010.

J. Tsai, P. H. Lysaker, and J. L. Vohs, Negative symptoms and concomitant attention deficits in schizophrenia: associations with prospective assessments of anxiety, social dysfunction, and avoidant coping, J Ment Health, vol.19, pp.184-192, 2010.

J. M. Morrison and G. Myhr, Theory of mind and global empathy performance in schizophrenia: the role of anxiety, remission status and symptom type, Schizophr Res, vol.117, p.327, 2010.

P. H. Lysaker, P. T. Yanos, and J. Outcalt, Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia, Clin Schizophr Relat Psychoses, vol.4, pp.41-48, 2010.

R. J. Braga, G. Petrides, and I. Figueira, Anxiety disorders in schizophrenia, Comp Psychiatry, vol.45, pp.460-468, 2004.

R. J. Braga, M. V. Mendlowicz, and R. P. Marrocos, Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life, J Psychiatric Res, vol.39, pp.409-414, 2005.

J. D. Huppert and T. E. Smith, Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor, J Nerv Ment Dis, vol.189, pp.669-675, 2001.

J. D. Huppert, K. A. Weiss, and R. Lim, Quality of life in schizophrenia: contributions of anxiety and depression, Schizophr Res, vol.51, pp.171-180, 2001.

P. H. Lysaker, G. Salvatore, and M. Grant, Deficits in theory of mind and social anxiety as independent paths to paranoid features in schizophrenia, Schizophr Res, vol.124, pp.81-85, 2010.

, Eur Arch Psychiatry Clin Neurosci, vol.264, pp.171-178, 2014.

J. F. Allilaire, Angoisse psychotique et angoisse névrotique, Différence qualitative ou différence quantitative? L'Encéphale 9, pp.211-216, 1983.

J. L. Cutler and S. G. Siris, Panic-like'' symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: observations and implications, Comp Psychiatry, vol.32, pp.465-473, 1991.

F. J. Baylé, O. Blanc, and I. De-chazeron, Prise en charge médicamenteuse de l'anxiété chez le patient souffrant de schizophrénie, L'Encéphale, vol.37, pp.83-89, 2011.

O. Blin, J. M. Azorin, and Y. Lecrubier, Psychotic anxiety scale (PAS): évaluation de la fidélité intercotateurs et analyse factorielle des correspondances, L'Encéphale, vol.15, pp.543-547, 1989.

J. L. Romain, P. Dermain, and P. Greslé, Efficacité de l'acétate de zuclopenthixol sur l'anxiété psychotique évaluée lors d'une étude ouverte, L'Encéphale, vol.22, pp.280-286, 1996.

O. Blin, J. M. Azorin, and P. Bouhours, Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients, J Clin Psychopharmacol, vol.16, pp.38-44, 1996.

M. Hamilton, The assessment of anxiety states by rating, Br J Med Psychol, vol.32, pp.50-55, 1959.

P. Tyrer, R. T. Owen, and D. V. Cicchetti, The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale, J Neurol Neurosurg Psychiatry, vol.47, pp.970-975, 1984.

W. Guy and T. A. Ban, The AMDP-System. Manual for the assessment and documentation of psychopathology, 1982.

M. Asberg, S. A. Montgomery, and C. Perris, A comprehensive psychopathological rating scale, Acta Psychiatrica Scandinavica Suppl, vol.271, pp.5-27, 1978.

J. D. Guelfi, L. Waintraub, and J. Fermanian, La version française de la CPRS: analyse factorielle sur un échantillon de 208 patients, L'Encéphale, vol.2, pp.395-400, 1987.

P. Pichot and C. B. Pull, Une analyse factorielle de l'échelle d'appréciation de l'anxiété de Hamilton, pp.183-189, 1981.

A. Lesur, D. Bonnet, and E. Vicaut, L'échelle brève d'anxiété de Tyrer en pratique extrahospitalière: première validation en langue française, L' Encéphale, vol.15, pp.535-542, 1989.

D. Bobon, R. Von-frenckell, and B. Troisfontaines, Preliminary construction and validation of an anxiety scale derived from the French version of the AMDP, the AMDP-AT, Encephale, vol.11, pp.107-111, 1985.

R. Likert, A technique for the measurement of attitudes, Archives Psychol, vol.140, pp.5-55, 1932.

C. Bowles-n-;-lançon, C. Aghababian, P. Llorca, . Bd, and P. Auquier, An exploration of the psychometric properties of the French-language version of the positive and negative syndrome scale (PANSS), Can J Psychiatry, vol.13, pp.893-900, 1999.

H. F. Kaiser, An index of factorial simplicity, Psychometrika, vol.39, pp.31-36, 1974.

C. Lance and M. C. Michels, The sources of four commonly reported cutoff criteria, what did they really say?, Organizational Res Meth, vol.9, pp.202-220, 2006.

P. E. Shrout and J. L. Fleiss, Intraclass correlations: uses in assessing rater reliability, Psychol Bull, vol.86, pp.420-428, 1979.

P. Kline, An easy guide to factor analysis, 1994.

S. R. Kay, A. Fiszbein, and L. A. Opler, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophrenia Bull, vol.13, pp.261-274, 1987.

J. D. Huppert and T. E. Smith, Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms, CNS Spectr, vol.10, pp.721-731, 2005.

J. Peuskens, B. Van-baelen, D. Smedt, and C. , Effects of risperidone on affective symptoms in patients with schizophrenia, Int Clin Psychopharmacol, vol.15, pp.343-349, 2000.

G. D. Tollefson, T. M. Sanger, and Y. Lu, Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol, Arch Gen Psychiatry, vol.55, pp.250-258, 1998.

B. J. Kinon, H. Ascher-svanum, and D. H. Adams, The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials, J Clin Psychopharmacol, vol.28, pp.544-549, 2008.

J. M. Danion, W. Rein, and O. Fleurot, Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride, Am J Psychiatry, vol.156, pp.610-616, 1999.

S. Dollfus, V. Olivier, and B. Chabot, Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients, Schizophr Res, vol.78, pp.157-159, 2005.

S. W. Kim, I. S. Shin, and J. M. Kim, Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial, Prog Neuropsychopharmacol Biol Psychiatry, vol.31, pp.1504-1509, 2007.